Keyphrases
Oligodendrocyte
100%
Spinal Cord Injury
100%
Methylprednisolone
100%
RU486
33%
Protective Effect
25%
Bcl-xL
16%
Caspase-3 Activation
16%
Anti-apoptotic
16%
Immunoreactive Cells
16%
Receptor-mediated
8%
Glucocorticoid Receptor
8%
Cell number
8%
Demyelination
8%
White Matter Injury
8%
Oligodendrocyte Death
8%
Mediated Action
8%
Dose Effect
8%
DNA Laddering
8%
Staurosporine
8%
Small Interfering RNA (siRNA)
8%
Nuclear Proteins
8%
Neuronal Cell Death
8%
Multiple Sclerosis
8%
Mechanism of Action
8%
Anti-inflammatory Properties
8%
Neurological Disorders
8%
Acute Disseminated Encephalomyelitis
8%
Phenyl
8%
Antioxidant Properties
8%
Blue Staining
8%
Luxol Fast Blue
8%
Glucocorticoid Receptor Antagonist
8%
Neuroprotective Activity
8%
Dimethylamino
8%
Selective Protection
8%
Neuroscience
Oligodendrocyte
100%
Methylprednisolone
100%
Spinal Cord Injury
100%
Mifepristone
33%
AMPA
16%
Caspase 3
16%
Glucocorticoid Receptor
16%
Receptor
16%
Staining Technique
8%
In Vivo
8%
Receptor Antagonist
8%
Staurosporine
8%
Neuronal Cell Death
8%
Neuroprotective Agent
8%
Nervous System Disorder
8%
Multiple Sclerosis
8%
Small Interfering RNA
8%
Acute Disseminated Encephalomyelitis
8%
Antioxidant
8%
DNA Laddering
8%
Estrone
8%
Neuron Specific Nuclear Protein
8%
Pharmacology, Toxicology and Pharmaceutical Science
Spinal Cord Injury
100%
Methylprednisolone
100%
Mifepristone
33%
Receptor
16%
Antiapoptotic
16%
Caspase 3
16%
Alpha Amino 3 Hydroxy 5 Methyl 4 Isoxazolepropionic Acid
16%
Glucocorticoid Receptor
8%
Small Interfering RNA
8%
Antioxidant
8%
Staurosporine
8%
Estrone
8%
Multiple Sclerosis
8%
Demyelination
8%
Neuroprotective Agent
8%
DNA Laddering
8%
White Matter Injury
8%
Acute Disseminated Encephalomyelitis
8%
Glucocorticoid Receptor Antagonist
8%
Neuron Specific Nuclear Protein
8%
Fast Blue
8%